Patient allegedly received an implant in (b)(6) 2010 via right common femoral vein due to pre-orthopedic surgery.Patient is alleging tilt, vena cava/organ perforation.The patient further alleges occlusion and thrombus.The patient further alleges post-implant deep vein thrombosis (dvt)/blood clots and pulmonary embolism (pe) requiring medical treatment.Per a report from thrombectomy; ¿impression: 1.Occluded infrarenal ivc below previously placed filter that extends on the left into the common and external iliac veins and common iliac vein on the right.¿ per a report from thrombectomy; ¿impression: marked interval improvement of ivc and iliac thrombus status post overnight catheter directed thrombolysis.Successful venoplasty of the ivc and left common iliac vein with gentle push thrombectomy.At the conclusion of venoplasty, there was roughly 80% thrombus resolution.¿ per a report from venogram; ¿summary: successful thrombolysis of residual clot in the ivc and bilateral common iliac veins via balloon venoplasty, pharmacomechanical therapy, and gentle push thrombectomy.At the conclusion of the case, the ivc and iliac veins are widely patent.Infrarenal ivc filter was left in place.¿ per a report from computed tomography (ct); ¿findings: there is an ivc filter in place with the cephalad tip of the filter at the level of the inferior aspect of the l2 vertebra.Four main prongs and eight smaller prongs are notes suggesting a cook celect type of filter.The four main prongs are extraluminal in location.The anterior prong abuts a small vein likely the gonadal vein.The medial prong abuts the right lateral aspect of the aorta.The right lateral prong is surrounded by fat and the posterior prong abuts an osteophyte at the l3-4 disc level.The eight other smaller prongs are intraluminal.There is tilting of the filter with the cephalad aspect of the filter abutting the left lateral wall of the ivc just caudal to the level of the left renal vein.No evidence of retroperitoneal hemorrhage.No evidence of aortic rupture or aneurysm.¿.
|
Investigation: investigation is reopened due to additional information provided.The reported allegations have been further investigated based on the information provided to date.The following allegations have been investigated: pulmonary embolism (pe), vena cava (vc)/organ perforation, deep vein thrombosis (dvt)/occlusion/thrombus/blood clots, tilt.New pe as a reported complication, is a known risk in relation to filter implant and is well documented in the clinical literature and in clinical practice guidelines.This is supported by the clinical evidence report established to assess available clinical data to identify and evaluate the clinical safety and performance of the cook vena cava filters.Potential adverse events that may occur include, but are not limited to, the following: pulmonary embolism.Filter interacts with ivc wall, e.G.Penetration/perforation/embedment.This may be either symptomatic or asymptomatic.Potential causes may include improper deployment; and (or) excessive force or manipulations near an in-situ filter (e.G., a surgical or endovascular procedure in the vicinity of a filter).Potential adverse events that may occur include, but are not limited to, the following: trauma to adjacent structures, vascular trauma, vena cava perforation, vena cava penetration.Ivc occlusion/ thrombosis, new dvt, ivc stenosis as a reported complication, is a known risk in relation to filter implant and is well documented in the clinical literature and in clinical practice guidelines.This is supported by the clinical evidence report established to assess available clinical data to identify and evaluate the clinical safety and performance of the cook vena cava filters.Potential adverse events that may occur include, but are not limited to, the following: vena cava occlusion or thrombosis, vena cava stenosis, deep vein thrombosis.Filter tilt has been reported.Potential causes may include filter placement in ivcs with diameters larger than those specified in these instructions for use; improper deployment; manipulations near an implanted filter (e.G., a surgical or endovascular procedure in the vicinity of a filter); and (or) a failed retrieval attempt.Excessive filter tilt may contribute to difficult or failed retrieval; vena cava wall penetration/perforation; and (or) result in loss of filter efficiency.Potential adverse events that may occur include, but are not limited to, the following: unacceptable filter tilt.20 devices in lot.No relevant notes on work order.The product is manufactured and inspected according to specifications.No evidence to suggest that this device was not manufactured according to specifications and nothing indicates that the filter did not perform as intended, e.G.Intended for the prevention of recurrent pulmonary embolism (pe) via placement in the vena cava.Cook will reopen its investigation if further information is received warranting supplementation in accordance with 21 c.F.R.803.56.This report includes information known at this time.A follow-up medwatch report will be submitted if additional relevant information becomes available.This report is required by the fda under 21 cfr part 803.This report is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement made in it is intended to be an admission that any cook device is defective or malfunctioned, that a death or serious injury occurred, or that any cook device caused or contributed to or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
|
Blank fields on this form indicate the information is unknown, unavailable, or unchanged.The following fields were updated per additional information received: b5, and h6.Investigation the following allegations have been investigated: anxiety.Investigation is reopened due to additional information provided.The reported allegations have been further investigated based on the information provided to date.Unknown if the reported anxiety is directly related to the filter and unable to identify a corresponding failure mode at this point in time.20 devices in lot.No relevant notes on work order.The product is manufactured and inspected according to specifications.No evidence to suggest that this device was not manufactured according to specifications and nothing indicates that the filter did not perform as intended, e.G.Intended for the prevention of recurrent pulmonary embolism (pe) via placement in the vena cava.Cook will reopen its investigation if further information is received warranting supplementation in accordance with 21 c.F.R.803.56.This report includes information known at this time.A follow-up medwatch report will be submitted if additional relevant information becomes available.This report is required by the fda under 21 cfr part 803.This report is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement made in it is intended to be an admission that any cook device is defective or malfunctioned, that a death or serious injury occurred, or that any cook device caused or contributed to or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
|